Roth Capital Issues Optimistic Estimate for Celsius Earnings

Celsius Holdings Inc. (NASDAQ:CELH) – Investment analysts at Roth Capital upped their Q2 2026 earnings per share estimates for shares of Celsius in a report released on Tuesday, September 2nd. Roth Capital analyst S. Mcgowan now forecasts that the company will post earnings of $0.46 per share for the quarter, up from their previous estimate of $0.45. Roth Capital currently has a “Buy” rating and a $70.00 price target on the stock. The consensus estimate for Celsius’ current full-year earnings is $0.89 per share. Roth Capital also issued estimates for Celsius’ Q3 2026 earnings at $0.39 EPS, Q4 2026 earnings at $0.36 EPS, FY2026 earnings at $1.42 EPS and FY2027 earnings at $1.95 EPS.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The business had revenue of $739.30 million during the quarter, compared to analysts’ expectations of $632.13 million. During the same quarter in the previous year, the firm earned $0.28 EPS. The firm’s revenue was up 83.9% compared to the same quarter last year.

Several other equities analysts have also recently weighed in on CELH. Stephens reissued an “overweight” rating on shares of Celsius in a research report on Monday, August 11th. TD Cowen raised Celsius from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $37.00 to $55.00 in a research report on Monday, June 16th. Stifel Nicolaus boosted their price target on Celsius from $56.00 to $70.00 and gave the company a “buy” rating in a research note on Tuesday. Jefferies Financial Group set a $72.00 price target on Celsius in a research note on Wednesday. Finally, Morgan Stanley boosted their price target on Celsius from $56.00 to $61.00 and gave the company an “equal weight” rating in a research note on Tuesday. Seventeen research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $59.37.

Celsius Price Performance

NASDAQ CELH opened at $61.10 on Wednesday. Celsius has a twelve month low of $21.10 and a twelve month high of $63.50. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The stock has a market capitalization of $15.76 billion, a PE ratio of 165.14, a P/E/G ratio of 1.43 and a beta of 1.34. The stock has a 50-day simple moving average of $50.76 and a 200 day simple moving average of $40.52.

Institutional Investors Weigh In On Celsius

Several large investors have recently modified their holdings of CELH. Alliancebernstein L.P. grew its stake in shares of Celsius by 26.3% in the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after purchasing an additional 3,753,055 shares during the period. Scopus Asset Management L.P. bought a new stake in shares of Celsius in the 2nd quarter valued at approximately $59,382,000. Ilex Capital Partners UK LLP bought a new stake in shares of Celsius in the 2nd quarter valued at approximately $55,966,000. Holocene Advisors LP grew its stake in shares of Celsius by 130.6% in the 2nd quarter. Holocene Advisors LP now owns 2,108,041 shares of the company’s stock valued at $97,792,000 after purchasing an additional 1,193,707 shares during the period. Finally, AQR Capital Management LLC bought a new stake in shares of Celsius in the 1st quarter valued at approximately $39,412,000. 60.95% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CFO Jarrod Langhans sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $60.00, for a total value of $300,000.00. Following the sale, the chief financial officer directly owned 104,227 shares in the company, valued at approximately $6,253,620. This represents a 4.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, major shareholder Deborah Desantis sold 100,000 shares of the company’s stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the completion of the sale, the insider owned 17,717,770 shares in the company, valued at approximately $841,594,075. This represents a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,116,141 shares of company stock valued at $52,541,605. 2.20% of the stock is currently owned by company insiders.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.